These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

73 related articles for article (PubMed ID: 3719629)

  • 1. [Normal natural killer activity (NK-activity) in patients on a chronic dialysis program].
    Písa P; Jíra M; Horký J; Strejcek J
    Cas Lek Cesk; 1986 Apr; 125(17):527-30. PubMed ID: 3719629
    [No Abstract]   [Full Text] [Related]  

  • 2. [Studies on immune deficiency in chronic renal failure. II. Natural killer activity and effect of interleukin 2 on natural killer activity in chronic hemodialysis patients].
    Yoshida K
    Nihon Jinzo Gakkai Shi; 1988 Jun; 30(6):721-7. PubMed ID: 3262782
    [No Abstract]   [Full Text] [Related]  

  • 3. [Immunological findings in kidney insufficiency with and without hemodialysis. II. K cell activity under chronic hemodialysis conditions].
    Varga A; Stosiek P; Lincke HU
    Z Urol Nephrol; 1980 May; 73(5):367-71. PubMed ID: 7456804
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Postoperative immunological capacity after coronary artery bypass grafting in a patient with chronic hemodialysis: comparison with data from patients without chronic hemodialysis].
    Shirasawa B; Hamano K; Ito H; Gohra H; Katoh T; Fujimura Y; Tsuboi H; Esato K
    Kyobu Geka; 1996 Sep; 49(10):809-12. PubMed ID: 8828323
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Decreased CD3+CD16+ natural killer-like T-cell percentage and zeta-chain expression accompany chronic inflammation in haemodialysis patients.
    Eleftheriadis T; Kartsios C; Yiannaki E; Antoniadi G; Kazila P; Pliakos K; Liakopoulos V; Markala D
    Nephrology (Carlton); 2009 Aug; 14(5):471-5. PubMed ID: 19486472
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Natural killer cell alterations correlate with loss of renal function and dialysis duration in uraemic patients.
    Vacher-Coponat H; Brunet C; Lyonnet L; Bonnet E; Loundou A; Sampol J; Moal V; Dussol B; Brunet P; Berland Y; Dignat-George F; Paul P
    Nephrol Dial Transplant; 2008 Apr; 23(4):1406-14. PubMed ID: 18029366
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Depressed polymorphonuclear leukocyte functions associated with normal cytotoxic functions of T and natural killer cells during chronic hemodialysis.
    Charpentier B; Lang P; Martin B; Noury J; Mathieu D; Fries D
    Clin Nephrol; 1983 Jun; 19(6):288-94. PubMed ID: 6603319
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Increase of peripheral natural killer T cells in hemodialysis patients.
    Nishimoto A; Matsumoto Y
    Clin Nephrol; 2001 Feb; 55(2):121-6. PubMed ID: 11269675
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Natural killer-cell activity after human renal transplantation in relation to killer immunoglobulin-like receptors and human leukocyte antigen mismatch.
    Vampa ML; Norman PJ; Burnapp L; Vaughan RW; Sacks SH; Wong W
    Transplantation; 2003 Oct; 76(8):1220-8. PubMed ID: 14578757
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Characteristics of the biological role of spontaneous killer cells in humans].
    Zaretskaia IuM; Burkhanov RA
    Biull Eksp Biol Med; 1982 Mar; 93(3):104-6. PubMed ID: 7046831
    [No Abstract]   [Full Text] [Related]  

  • 11. Impaired NK cell function in ESRD patients.
    Lonnemann G
    Blood Purif; 2008; 26(4):315-6. PubMed ID: 18463432
    [No Abstract]   [Full Text] [Related]  

  • 12. [Antibody-dependent and natural cellular cytotoxicity in patients with dilated cardiomyopathy].
    Bakhov NI; Aleksandrova LZ; Osipov SG; Naumov VG; Rudnev VI
    Ter Arkh; 1986; 58(10):62-7. PubMed ID: 3798351
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Decreased natural killer cytotoxic activity in chronic alcoholism is associated with alcohol liver disease but not active ethanol consumption.
    Laso FJ; Madruga JI; Girón JA; López A; Ciudad J; San Miguel JF; Alvarez-Mon M; Orfao A
    Hepatology; 1997 May; 25(5):1096-100. PubMed ID: 9141423
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Immunological studies on Crohn's disease. III. Defective natural killer activity.
    Okabe N; Fujita K; Yao T
    J Clin Lab Immunol; 1985 Jul; 17(3):143-6. PubMed ID: 4046002
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Defective natural killer (NK) and killer (K) cell function in systemic lupus erythematosus.
    Ewan PW; Barrett HM; Pusey CD
    J Clin Lab Immunol; 1983 Feb; 10(2):71-6. PubMed ID: 6842577
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Chronic inflammation and CD16+ natural killer cell zeta-chain downregulation in hemodialysis patients.
    Eleftheriadis T; Kartsios C; Yiannaki E; Kazila P; Antoniadi G; Liakopoulos V; Markala D
    Blood Purif; 2008; 26(4):317-21. PubMed ID: 18463433
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Deficient natural killer cell activity in alcoholic cirrhosis.
    Charpentier B; Franco D; Paci L; Charra M; Martin B; Vuitton D; Fries D
    Clin Exp Immunol; 1984 Oct; 58(1):107-15. PubMed ID: 6236915
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Natural killer (NK) activity in patients with chronic granulomatous disease.
    Tanaka Y; Sakano T; Usui T
    Hiroshima J Med Sci; 1981 Jun; 30(2):135-9. PubMed ID: 7298359
    [No Abstract]   [Full Text] [Related]  

  • 19. Suppression of natural killer cell activity by serum derived from head and neck cancer patients.
    Kumazawa H; Minamino M; Yukawa N; Hess M
    Cancer Detect Prev; 1995; 19(6):494-502. PubMed ID: 8925518
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Natural killer cell activity in families of patients with systemic lupus erythematosus: demonstration of a killing defect in patients.
    Green MR; Kennell AS; Larche MJ; Seifert MH; Isenberg DA; Salaman MR
    Clin Exp Immunol; 2005 Jul; 141(1):165-73. PubMed ID: 15958083
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.